Entity family
Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.
Showing 541–600 of 9,496, ordered by supporting articles. Choose a drug to see its evidence.
…static MTC. In the setting of progressive metastatic MTC, TKIs (selpercatinib, cabozantinib and vandetanib) can prolong survival for some pat…
…sis, achieved superior tumor growth inhibition and outperformed mirvetuximab soravtansine. Our data highlights the therapeutic potential and tolerability…
…bability of cost-effectiveness increased to 73%.Conclusion Oral morphine for chronic breathlessness is likely to be a cost-effective int…
… and HF hospitalisations during 1 year of follow-up.Results The PAGln levels were significantly higher in IHD patients compared with …
…ticipants (1026 biosimilar, 1018 reference) were included. Five aflibercept biosimilars were evaluated, representing more than 50% of the e…
…Introduction In the UK, short-acting β2-agonist (SABA) overuse in asthma remains common; however, this treatment stra…
…Conclusions In patients with type 2, moderate-to-severe asthma, dupilumab significantly increased spirometry-derived ratios, indicating i…
…hese data contribute to the growing evidence of the efficacy of tezepelumab in patients with CRS, including CRSwNP.…
… of 22.2 months (95% CI 18.1–26.2), 51% of patients interrupted nintedanib due to diarrhoea (33%), nausea/vomiting (21%), reflux (2%), wei…
…sed with or without RV-16 infections.Conclusions We established ORMDL3 KO epithelial cells, which have shown to response to different …
…mediate result which shows they may benefit from treatment with inhaled corticosteroids if they are symptomatic. Only 3.6% of patients were unable to p…